Zentrum für Onkologische Oberbauchchirurgie und Robotik, Krankenhaus Waldfriede, Akademisches Lehrkrankenhaus der Charité, Berlin, Germany.
Expert Rev Anticancer Ther. 2022 Sep;22(9):939-946. doi: 10.1080/14737140.2022.2105211. Epub 2022 Jul 26.
Robotic surgery is an emerging aspect of gastrointestinal surgery. Hepato-pancreato-biliary surgery is currently being explored for a broad spectrum of indications, entities, and postoperative outcomes. Noninferiority and financial aspects are the focus of studies. In this review, the impact on oncological therapies is assessed.
An extensive literature review was conducted, and relevant studies and articles and reviews for robotic surgery in the field of hepato-pancreato-biliary surgery were examined. Special attention was given to the oncological aspects of robotic surgery and its possible impact on the therapy of malignant neoplasms.
Robotic-assisted surgery for oncological indications is promising, in part, an established technique that has already shown its advantages in the last decade, although high-quality studies are missing. Upcoming experience must consider the oncological benefit and putative new indications in a rapidly changing field of anti-neoplastic regimens. Also, robotic surgery may possess the ability to accelerate digitalization and AI-based augmentation in this context.
机器人手术是胃肠外科学的一个新兴领域。肝胆胰外科学目前正在广泛探索各种适应证、实体和术后结果。非劣效性和财务方面是研究的重点。在本综述中，评估了对肿瘤治疗的影响。
进行了广泛的文献回顾，并对机器人手术在肝胆胰外科学领域的相关研究和文章进行了审查。特别关注机器人手术的肿瘤学方面及其对恶性肿瘤治疗的可能影响。
机器人辅助手术用于肿瘤学适应证具有广阔的前景，部分原因是这项技术已经在过去十年中显示出了其优势，尽管目前还缺乏高质量的研究。未来的经验必须考虑到在抗肿瘤方案快速变化的背景下，肿瘤学获益和推测的新适应证。此外，机器人手术在这种情况下可能具有加速数字化和基于人工智能增强的能力。
